AURYXIA®

Drug Information Related Patent
Hold Company
KERYX BIOPHARMS
Learn More
Dosage and Administration
TABLET;ORAL
Specification
EQ 210MG IRON
Indication
AURYXIA® is used in chronic kidney disease dialysis patients with hyperphosphatemia and non-dialysis chronic kidney disease iron deficiency anemia.
Use
Instructions for Use
API
FERRIC CITRATE
API Structure
We Supply
FERRIC CITRATE
Note:

In-house Standard
Facility GMP
DMF

null
Note:

null

null
Note:

null

Drug Patent
Patent NoExpiration Date
103000392030/7/21
77678512024/2/18
80934232026/4/21
82992982024/2/18
83386422024/2/18
86098962024/2/18
87542572024/2/18
87542582024/2/18
88469762024/2/18
89013492024/2/18
90503162024/2/18
93281332024/2/18
93871912030/7/21
97574162024/2/18
API Patent
Patent NoExpiration Date
80934232026/4/21
82992982024/2/18
83386422024/2/18
86098962024/2/18
87542572024/2/18
87542582024/2/18
88469762024/2/18
89013492024/2/18
90503162024/2/18
93281332024/2/18
97574162024/2/18
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

INFORMATION
CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen-ING. All Rights Reserved.
dcat
Member of
dcat
Top